MARCO Antibody (579511) [Janelia Fluor® 585]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2956JF585
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 585
Antibody Source
Monoclonal Rat IgG1 Clone # 579511
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse MARCO
Gln70-Ser518
Accession # Q60754
Gln70-Ser518
Accession # Q60754
Specificity
Detects mouse MARCO in direct ELISAs.
Clonality
Monoclonal
Host
Rat
Isotype
IgG1
Applications for MARCO Antibody (579511) [Janelia Fluor® 585]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: MARCO
Long Name
Macrophage Receptor with Collagenous Structure/Scavenger Receptor, Class A, Member 2
Alternate Names
SCARA2
Additional MARCO Products
Product Documents for MARCO Antibody (579511) [Janelia Fluor® 585]
Product Specific Notices for MARCO Antibody (579511) [Janelia Fluor® 585]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...